Last 12 months
Inside the activity.
0 purchase rows · 71 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 16 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 19 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 14 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 22 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 21, 2017 Filed Mar 23, 2017 22:40 UTC |
Hutchinson Michael DamonGeneral Counsel
|
Tax withholdingCommon Stock | 382 | $132.59 | $50,649.38 |
DisclosureSEC source: 0000310764-17-000082 · edgar.xml · nonDerivative · entry 2 Hutchinson Michael David · CIK 0001606626 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,813 Read SEC document |
| March 21, 2017 Filed Mar 23, 2017 22:40 UTC |
Hutchinson Michael DamonGeneral Counsel
|
Exercise / conversionCommon Stock | 1,027 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-17-000082 · edgar.xml · nonDerivative · entry 1 Hutchinson Michael David · CIK 0001606626 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,195 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On March 21, 2017, 1,027 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. F2 · balance_after: Includes 390 shares of Stryker Common Stock acquired pursuant to Stryker Corporation's Employee Stock Purchase Plan ("ESPP") as of December 31, 2016, the date of the latest available statement of the reporting person's ESPP holdings. Read SEC document |
| March 21, 2017 Filed Mar 23, 2017 22:44 UTC |
Floyd DavidGroup President, Orthopaedics
|
Tax withholdingCommon Stock | 7,448 | $132.59 | $987,530.32 |
DisclosureSEC source: 0000310764-17-000084 · edgar.xml · nonDerivative · entry 2 Floyd David · CIK 0001564203 · Group President, Orthopaedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,220 Read SEC document |
| March 21, 2017 Filed Mar 23, 2017 22:44 UTC |
Floyd DavidGroup President, Orthopaedics
|
GrantCommon Stock | 15,208 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-17-000084 · edgar.xml · nonDerivative · entry 1 Floyd David · CIK 0001564203 · Group President, Orthopaedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,668 F1 · shares: Shares issued upon vesting of Performance Stock Units, and related dividend equivalents, that were earned based on the achievement of pre-established three-year average adjusted diluted net earnings per share goals and sales performance goals. F1 · price: Shares issued upon vesting of Performance Stock Units, and related dividend equivalents, that were earned based on the achievement of pre-established three-year average adjusted diluted net earnings per share goals and sales performance goals. F2 · balance_after: Includes 460 shares of Stryker Common Stock acquired pursuant to Stryker Corporation's Employee Stock Purchase Plan ("ESPP") as of December 31, 2016, the date of the latest available statement of the reporting person's ESPP holdings. Read SEC document |
| March 21, 2017 Filed Mar 23, 2017 22:56 UTC |
Lobo KevinPresident and CEO
|
Tax withholdingCommon Stock | 32,035 | $132.59 | $4,247,520.65 |
DisclosureSEC source: 0000310764-17-000085 · edgar.xml · nonDerivative · entry 2 Lobo Kevin · CIK 0001519419 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,647 Read SEC document |
| March 21, 2017 Filed Mar 23, 2017 22:56 UTC |
Lobo KevinPresident and CEO
|
GrantCommon Stock | 61,781 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-17-000085 · edgar.xml · nonDerivative · entry 1 Lobo Kevin · CIK 0001519419 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,682 F1 · shares: Shares issued upon vesting of Performance Stock Units, and related dividend equivalents, that were earned based on the achievement of pre-established three-year average adjusted diluted net earnings per share goals and sales performance goals. F1 · price: Shares issued upon vesting of Performance Stock Units, and related dividend equivalents, that were earned based on the achievement of pre-established three-year average adjusted diluted net earnings per share goals and sales performance goals. F2 · balance_after: Includes 1,533 shares of Stryker Common Stock acquired pursuant to Stryker Corporation's Employee Stock Purchase Plan ("ESPP") as of December 31, 2016, the date of the latest available statement of the reporting person's ESPP holdings. Read SEC document |
| March 21, 2017 Filed Mar 24, 2017 00:01 UTC |
McLean Graham APresident, Asia-Pacific
|
Exercise / conversionRestricted Stock Units granted 02-10-2016 · Derivative | 621 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310764-17-000089 · edgar.xml · derivative · entry 6 McLean Graham A · CIK 0001693660 · President, Asia-Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,242 Underlying: Common Stock · 621 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: On March 21, 2017, 621 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. F3 · price: On March 21, 2017, 621 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. F5 · derivative.exercise_date: The Restricted Stock Units vest as to 621 shares on March 21, 2018 and 621 shares on March 21, 2019. F5 · derivative.expiration_date: The Restricted Stock Units vest as to 621 shares on March 21, 2018 and 621 shares on March 21, 2019. Read SEC document |
| March 21, 2017 Filed Mar 24, 2017 00:01 UTC |
McLean Graham APresident, Asia-Pacific
|
Exercise / conversionRestricted Stock Units granted 02-11-2015 · Derivative | 609 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310764-17-000089 · edgar.xml · derivative · entry 5 McLean Graham A · CIK 0001693660 · President, Asia-Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 609 Underlying: Common Stock · 609 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: On March 21, 2017, 609 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. F2 · price: On March 21, 2017, 609 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units vest as to 609 shares on March 21, 2018. F4 · derivative.expiration_date: The Restricted Stock Units vest as to 609 shares on March 21, 2018. Read SEC document |
| March 21, 2017 Filed Mar 24, 2017 00:01 UTC |
McLean Graham APresident, Asia-Pacific
|
Exercise / conversionRestricted Stock Units granted 02-12-2014 · Derivative | 863 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310764-17-000089 · edgar.xml · derivative · entry 4 McLean Graham A · CIK 0001693660 · President, Asia-Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 863 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On March 21, 2017, 863 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. F1 · price: On March 21, 2017, 863 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. F1 · derivative.exercise_date: On March 21, 2017, 863 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. F1 · derivative.expiration_date: On March 21, 2017, 863 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. Read SEC document |
| March 21, 2017 Filed Mar 24, 2017 00:01 UTC |
McLean Graham APresident, Asia-Pacific
|
Exercise / conversionCommon Stock | 621 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-17-000089 · edgar.xml · nonDerivative · entry 3 McLean Graham A · CIK 0001693660 · President, Asia-Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,893 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: On March 21, 2017, 621 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. Read SEC document |
| March 21, 2017 Filed Mar 24, 2017 00:01 UTC |
McLean Graham APresident, Asia-Pacific
|
Exercise / conversionCommon Stock | 609 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-17-000089 · edgar.xml · nonDerivative · entry 2 McLean Graham A · CIK 0001693660 · President, Asia-Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,272 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: On March 21, 2017, 609 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. Read SEC document |
| March 21, 2017 Filed Mar 24, 2017 00:01 UTC |
McLean Graham APresident, Asia-Pacific
|
Exercise / conversionCommon Stock | 863 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-17-000089 · edgar.xml · nonDerivative · entry 1 McLean Graham A · CIK 0001693660 · President, Asia-Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,663 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On March 21, 2017, 863 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. Read SEC document |
| March 21, 2017 Filed Mar 24, 2017 00:12 UTC |
Owen Katherine AnnV.P., Strategy & Investor Rel.
|
Tax withholdingCommon Stock | 2,377 | $132.59 | $315,166.43 |
DisclosureSEC source: 0000310764-17-000090 · edgar.xml · nonDerivative · entry 2 Owen Katherine Ann · CIK 0001485079 · V.P., Strategy & Investor Rel. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,296 Read SEC document |
| March 21, 2017 Filed Mar 24, 2017 00:12 UTC |
Owen Katherine AnnV.P., Strategy & Investor Rel.
|
GrantCommon Stock | 6,558 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-17-000090 · edgar.xml · nonDerivative · entry 1 Owen Katherine Ann · CIK 0001485079 · V.P., Strategy & Investor Rel. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,673 F1 · shares: Shares issued upon vesting of Performance Stock Units, and related dividend equivalents, that were earned based on the achievement of pre-established three-year average adjusted diluted net earnings per share goals and sales performance goals. F1 · price: Shares issued upon vesting of Performance Stock Units, and related dividend equivalents, that were earned based on the achievement of pre-established three-year average adjusted diluted net earnings per share goals and sales performance goals. Read SEC document |
| March 21, 2017 Filed Mar 24, 2017 00:24 UTC |
Scannell Timothy JGroup President
|
Tax withholdingCommon Stock | 10,097 | $132.59 | $1,338,761.23 |
DisclosureSEC source: 0000310764-17-000091 · edgar.xml · nonDerivative · entry 2 Scannell Timothy J · CIK 0001451533 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,971 Read SEC document |
| March 21, 2017 Filed Mar 24, 2017 00:24 UTC |
Scannell Timothy JGroup President
|
GrantCommon Stock | 19,959 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-17-000091 · edgar.xml · nonDerivative · entry 1 Scannell Timothy J · CIK 0001451533 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,068 F1 · shares: Shares issued upon vesting of Performance Stock Units, and related dividend equivalents, that were earned based on the achievement of pre-established three-year average adjusted diluted net earnings per share goals and sales performance goals. F1 · price: Shares issued upon vesting of Performance Stock Units, and related dividend equivalents, that were earned based on the achievement of pre-established three-year average adjusted diluted net earnings per share goals and sales performance goals. F2 · balance_after: Includes 82 shares of Stryker Common Stock acquired pursuant to Stryker Corporation's Employee Stock Purchase Plan ("ESPP") as of December 31, 2016, the date of the latest available statement of the reporting person's ESPP holdings. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 18:50 UTC |
Becker Yin CVP, Comm. and Public Affairs
|
SaleCommon Stock | 4,398 | $125.27 | $550,934.82 |
DisclosureSEC source: 0000310764-17-000057 · wf-form4_148735738938721.xml · nonDerivative · entry 1 Becker Yin C · CIK 0001663135 · VP, Comm. and Public Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,541 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2016. F2 · price: Represents the average price for transactions in a range from $124.94 to $125.78. Read SEC document |
| February 13, 2017 Filed Feb 14, 2017 18:03 UTC |
STRYKER RONDA EDirector
|
Exercise / conversionStock Option granted 2/14/2007 (right to buy) · Derivative | 7,700 | $62.65 Strike: $62.65 | $482,405.00 |
DisclosureSEC source: 0000310764-17-000055 · edgar.xml · derivative · entry 5 STRYKER RONDA E · CIK 0001242914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,700 shares Expires 2017-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Stock option granted pursuant to the Stryker Corporation 1998 Stock Option Plan, exercisable as to 20% on each of the first five anniversaries of date of grant. Read SEC document |
| February 13, 2017 Filed Feb 14, 2017 18:03 UTC |
STRYKER RONDA EDirector
|
Exercise / conversionCommon Stock | 7,700 | $62.65 | $482,405.00 |
DisclosureSEC source: 0000310764-17-000055 · edgar.xml · nonDerivative · entry 1 STRYKER RONDA E · CIK 0001242914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,842 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2017 Filed Feb 10, 2017 23:44 UTC |
Carpenter Lonny J.Group President
|
GiftCommon Stock | 470 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-17-000051 · edgar.xml · nonDerivative · entry 1 Carpenter Lonny J · CIK 0001451534 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,385 Read SEC document |
| February 08, 2017 Filed Feb 9, 2017 19:38 UTC |
Fink M KathrynVP, Chief HR Officer
|
GrantEmployee Stock Option granted 02/08/2017 (right to buy) · Derivative | 12,245 | $0.00 Strike: $122.51 | $0.00 |
DisclosureSEC source: 0000310764-17-000024 · edgar.xml · derivative · entry 1 Fink M Kathryn · CIK 0001663095 · VP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,245 Underlying: Common Stock · 12,245 shares Expires 2027-02-07 F1 · derivative.exercise_date: Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| February 08, 2017 Filed Feb 9, 2017 20:08 UTC |
McLean Graham APresident, Asia-Pacific
|
GrantEmployee Stock Option granted 2/8/2017 (right to buy) · Derivative | 9,695 | $0.00 Strike: $122.51 | $0.00 |
DisclosureSEC source: 0000310764-17-000027 · wf-form4_148667091729393.xml · derivative · entry 1 McLean Graham A · CIK 0001693660 · President, Asia-Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,695 Underlying: Common Stock · 9,695 shares Expires 2027-02-07 F1 · derivative.exercise_date: Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| February 08, 2017 Filed Feb 9, 2017 20:32 UTC |
COX HOWARD E JRDirector
|
GrantRestricted Stock Units granted 2/8/2017 · Derivative | 720 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000310764-17-000028 · wf-form4_148667234332341.xml · derivative · entry 2 COX HOWARD E JR · CIK 0000949117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 720 Underlying: Common Stock · 720 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Stryker common stock. F2 · price: Each restricted stock unit represents a contingent right to receive one share of Stryker common stock. F3 · derivative.exercise_date: The Restricted Stock Units vest as to 100% of the shares on March 21, 2018. F3 · derivative.expiration_date: The Restricted Stock Units vest as to 100% of the shares on March 21, 2018. Read SEC document |
| February 08, 2017 Filed Feb 9, 2017 20:32 UTC |
COX HOWARD E JRDirector
|
GrantStock Option granted 2/8/2017 (right to buy) · Derivative | 3,605 | $0.00 Strike: $122.51 | $0.00 |
DisclosureSEC source: 0000310764-17-000028 · wf-form4_148667234332341.xml · derivative · entry 1 COX HOWARD E JR · CIK 0000949117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,605 Underlying: Common Stock · 3,605 shares Expires 2027-02-07 F1 · derivative.exercise_date: Stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| February 08, 2017 Filed Feb 9, 2017 20:48 UTC |
Datar Srikant M.Director
|
GrantRestricted Stock Units granted 02/08/2017 · Derivative | 720 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-17-000030 · edgar.xml · derivative · entry 2 Datar Srikant · CIK 0001376436 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 720 Underlying: Common Stock · 720 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Stryker Common Stock. F2 · price: Each restricted stock unit represents a contingent right to receive one share of Stryker Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vest as to 100% of the shares on March 21, 2018. F3 · derivative.expiration_date: The Restricted Stock Units vest as to 100% of the shares on March 21, 2018. Read SEC document |
| February 08, 2017 Filed Feb 9, 2017 20:48 UTC |
Datar Srikant M.Director
|
GrantStock Option granted 02/08/2017 (right to buy) · Derivative | 3,605 | $0.00 Strike: $122.51 | $0.00 |
DisclosureSEC source: 0000310764-17-000030 · edgar.xml · derivative · entry 1 Datar Srikant · CIK 0001376436 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,605 Underlying: Common Stock · 3,605 shares Expires 2027-02-07 F1 · derivative.exercise_date: Stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| February 08, 2017 Filed Feb 9, 2017 20:55 UTC |
Doliveux RochDirector
|
GrantRestricted Stock Units granted 02/08/2017 · Derivative | 720 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-17-000031 · edgar.xml · derivative · entry 2 Doliveux Roch · CIK 0001494947 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 720 Underlying: Common Stock · 720 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Stryker Common Stock. F2 · price: Each restricted stock unit represents a contingent right to receive one share of Stryker Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vest as to 100% of the shares on March 21, 2018. F3 · derivative.expiration_date: The Restricted Stock Units vest as to 100% of the shares on March 21, 2018. Read SEC document |
| February 08, 2017 Filed Feb 9, 2017 20:55 UTC |
Doliveux RochDirector
|
GrantStock Option granted 02/08/2017 (right to buy) · Derivative | 3,605 | $0.00 Strike: $122.51 | $0.00 |
DisclosureSEC source: 0000310764-17-000031 · edgar.xml · derivative · entry 1 Doliveux Roch · CIK 0001494947 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,605 Underlying: Common Stock · 3,605 shares Expires 2027-02-07 F1 · derivative.exercise_date: Stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 13:38 UTC |
FRANCESCONI LOUISEDirector
|
GrantRestricted Stock Units granted 02/08/2017 · Derivative | 720 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-17-000035 · edgar.xml · derivative · entry 2 FRANCESCONI LOUISE · CIK 0001194786 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 720 Underlying: Common Stock · 720 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Stryker Common Stock. F2 · price: Each restricted stock unit represents a contingent right to receive one share of Stryker Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vest as to 100% of the shares on March 21, 2018. F3 · derivative.expiration_date: The Restricted Stock Units vest as to 100% of the shares on March 21, 2018. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 13:38 UTC |
FRANCESCONI LOUISEDirector
|
GrantStock Option granted 02/08/2017 (right to buy) · Derivative | 3,605 | $0.00 Strike: $122.51 | $0.00 |
DisclosureSEC source: 0000310764-17-000035 · edgar.xml · derivative · entry 1 FRANCESCONI LOUISE · CIK 0001194786 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,605 Underlying: Common Stock · 3,605 shares Expires 2027-02-07 F1 · derivative.exercise_date: Stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 13:44 UTC |
Golston Allan C.Director
|
GrantRestricted Stock Units granted 02/08/2017 · Derivative | 720 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-17-000036 · edgar.xml · derivative · entry 2 Golston Allan C. · CIK 0001509370 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 720 Underlying: Common Stock · 720 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Stryker Common Stock. F2 · price: Each restricted stock unit represents a contingent right to receive one share of Stryker Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vest as to 100% of the shares on March 21, 2018. F3 · derivative.expiration_date: The Restricted Stock Units vest as to 100% of the shares on March 21, 2018. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 13:44 UTC |
Golston Allan C.Director
|
GrantStock Option granted 02/08/2017 (right to buy) · Derivative | 3,605 | $0.00 Strike: $122.51 | $0.00 |
DisclosureSEC source: 0000310764-17-000036 · edgar.xml · derivative · entry 1 Golston Allan C. · CIK 0001509370 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,605 Underlying: Common Stock · 3,605 shares Expires 2027-02-07 F1 · derivative.exercise_date: Stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 13:55 UTC |
Lobo KevinPresident and CEO
|
GrantStock Option granted 02/08/2017 (right to buy) · Derivative | 193,860 | $0.00 Strike: $122.51 | $0.00 |
DisclosureSEC source: 0000310764-17-000037 · edgar.xml · derivative · entry 1 Lobo Kevin · CIK 0001519419 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,860 Underlying: Common Stock · 193,860 shares Expires 2027-02-07 F1 · derivative.exercise_date: Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 14:03 UTC |
Silvernail Andrew KDirector
|
GrantRestricted Stock Units granted 02/08/2017 · Derivative | 720 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-17-000038 · edgar.xml · derivative · entry 2 Silvernail Andrew K · CIK 0001485532 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 720 Underlying: Common Stock · 720 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Stryker Common Stock. F2 · price: Each restricted stock unit represents a contingent right to receive one share of Stryker Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vest as to 100% of the shares on March 21, 2018. F3 · derivative.expiration_date: The Restricted Stock Units vest as to 100% of the shares on March 21, 2018. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 14:03 UTC |
Silvernail Andrew KDirector
|
GrantStock Option granted 02/08/2017 (right to buy) · Derivative | 3,605 | $0.00 Strike: $122.51 | $0.00 |
DisclosureSEC source: 0000310764-17-000038 · edgar.xml · derivative · entry 1 Silvernail Andrew K · CIK 0001485532 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,605 Underlying: Common Stock · 3,605 shares Expires 2027-02-07 F1 · derivative.exercise_date: Stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 14:18 UTC |
STRYKER RONDA EDirector
|
GrantRestricted Stock Units granted 02/08/2017 · Derivative | 720 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-17-000039 · edgar.xml · derivative · entry 2 STRYKER RONDA E · CIK 0001242914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 720 Underlying: Common Stock · 720 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Stryker Common Stock. F2 · price: Each restricted stock unit represents a contingent right to receive one share of Stryker Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vest as to 100% of the shares on March 21, 2018. F3 · derivative.expiration_date: The Restricted Stock Units vest as to 100% of the shares on March 21, 2018. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 14:18 UTC |
STRYKER RONDA EDirector
|
GrantStock Option granted 02/08/2017 (right to buy) · Derivative | 3,605 | $0.00 Strike: $122.51 | $0.00 |
DisclosureSEC source: 0000310764-17-000039 · edgar.xml · derivative · entry 1 STRYKER RONDA E · CIK 0001242914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,605 Underlying: Common Stock · 3,605 shares Expires 2027-02-07 F1 · derivative.exercise_date: Stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 14:28 UTC |
Owen Katherine AnnVP, Strategy & Investor Rel.
|
GrantStock Option granted 02/08/2017 (right to buy) · Derivative | 18,365 | $0.00 Strike: $122.51 | $0.00 |
DisclosureSEC source: 0000310764-17-000040 · edgar.xml · derivative · entry 1 Owen Katherine Ann · CIK 0001485079 · VP, Strategy & Investor Rel. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,365 Underlying: Common Stock · 18,365 shares Expires 2027-02-07 F1 · derivative.exercise_date: Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 21:26 UTC |
Boehnlein Glenn SVP, Chief Financial Officer
|
GrantEmployee Stock Option granted 2/8/2017 (right to buy) · Derivative | 40,815 | $122.51 Strike: $122.51 | $5,000,245.65 |
DisclosureSEC source: 0000310764-17-000041 · wf-form4_148676199463091.xml · derivative · entry 1 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,815 Underlying: Common Stock · 40,815 shares Expires 2027-02-07 F1 · derivative.exercise_date: Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 22:05 UTC |
Becker Yin CVP, Comm & Public Affairs
|
GrantEmployee Stock Option granted 02/08/2017 (right to buy) · Derivative | 8,165 | $0.00 Strike: $122.51 | $0.00 |
DisclosureSEC source: 0000310764-17-000042 · edgar.xml · derivative · entry 1 Becker Yin C · CIK 0001663135 · VP, Comm & Public Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,165 Underlying: Common Stock · 8,165 shares Expires 2027-02-07 F1 · derivative.exercise_date: Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 22:20 UTC |
Hutchinson Michael DamonGeneral Counsel
|
GrantEmployee Stock Option granted 02/08/2017 (right to buy) · Derivative | 20,405 | $0.00 Strike: $122.51 | $0.00 |
DisclosureSEC source: 0000310764-17-000044 · edgar.xml · derivative · entry 1 Hutchinson Michael David · CIK 0001606626 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,405 Underlying: Common Stock · 20,405 shares Expires 2027-02-07 F1 · derivative.exercise_date: Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 22:27 UTC |
Floyd DavidGroup President, Orthopaedics
|
GrantEmployee Stock Option granted 02/08/2017 (right to buy) · Derivative | 55,100 | $0.00 Strike: $122.51 | $0.00 |
DisclosureSEC source: 0000310764-17-000046 · edgar.xml · derivative · entry 1 Floyd David · CIK 0001564203 · Group President, Orthopaedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,100 Underlying: Common Stock · 55,100 shares Expires 2027-02-07 F1 · derivative.exercise_date: Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 22:53 UTC |
Scannell Timothy JGroup President
|
GrantStock Option granted 02/08/2017 (right to buy) · Derivative | 59,180 | $0.00 Strike: $122.51 | $0.00 |
DisclosureSEC source: 0000310764-17-000048 · edgar.xml · derivative · entry 1 Scannell Timothy J · CIK 0001451533 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,180 Underlying: Common Stock · 59,180 shares Expires 2027-02-07 F1 · derivative.exercise_date: Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 22:43 UTC |
Sagar BijoyVP, Chief Information Officer
|
GrantRestricted Stock Units granted 02/08/2017 · Derivative | 2,448 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310764-17-000047 · edgar.xml · derivative · entry 2 Sagar Bijoy · CIK 0001614397 · VP, Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,448 Underlying: Common Stock · 2,448 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Stryker Common Stock. F2 · price: Each Restricted Stock Unit represents a contingent right to receive one share of Stryker Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vest as to 612 shares on March 21, 2018; 612 shares on March 21, 2019; and 1,224 shares on March 21, 2020. F3 · derivative.expiration_date: The Restricted Stock Units vest as to 612 shares on March 21, 2018; 612 shares on March 21, 2019; and 1,224 shares on March 21, 2020. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 22:43 UTC |
Sagar BijoyVP, Chief Information Officer
|
GrantEmployee Stock Option granted 02/08/2017 (right to buy) · Derivative | 9,695 | $0.00 Strike: $122.51 | $0.00 |
DisclosureSEC source: 0000310764-17-000047 · edgar.xml · derivative · entry 1 Sagar Bijoy · CIK 0001614397 · VP, Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,695 Underlying: Common Stock · 9,695 shares Expires 2027-02-07 F1 · derivative.exercise_date: Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 23:44 UTC |
Carpenter Lonny J.Group President
|
GrantEmployee Stock Option granted 02/08/2017 (right to buy) · Derivative | 46,935 | $0.00 Strike: $122.51 | $0.00 |
DisclosureSEC source: 0000310764-17-000051 · edgar.xml · derivative · entry 3 Carpenter Lonny J · CIK 0001451534 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,935 Underlying: Common Stock · 46,935 shares Expires 2027-02-07 F1 · derivative.exercise_date: Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| February 08, 2017 Filed Feb 11, 2017 00:19 UTC |
Berry William E JrVice President, Controller
|
GrantRestricted Stock Units granted 02/08/2017 · Derivative | 1,593 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-17-000052 · edgar.xml · derivative · entry 2 Berry William E Jr · CIK 0001600806 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,593 Underlying: Common Stock · 1,593 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Stryker Common Stock. F2 · price: Each restricted stock unit represents a contingent right to receive one share of Stryker Common Stock. F3 · derivative.exercise_date: The restricted stock units vest as to one-third of the shares on March 21, 2018; one-third of the shares on March 21, 2019; and the remaining one-third of the shares on March 21, 2020. F3 · derivative.expiration_date: The restricted stock units vest as to one-third of the shares on March 21, 2018; one-third of the shares on March 21, 2019; and the remaining one-third of the shares on March 21, 2020. Read SEC document |
| February 08, 2017 Filed Feb 11, 2017 00:19 UTC |
Berry William E JrVice President, Controller
|
GrantEmployee Stock Option granted 02/08/2017 (right to buy) · Derivative | 7,960 | $0.00 Strike: $122.51 | $0.00 |
DisclosureSEC source: 0000310764-17-000052 · edgar.xml · derivative · entry 1 Berry William E Jr · CIK 0001600806 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,960 Underlying: Common Stock · 7,960 shares Expires 2027-02-07 F1 · derivative.exercise_date: Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| January 31, 2017 Filed Feb 2, 2017 18:24 UTC |
Doliveux RochDirector
|
PurchaseCommon Stock | 41 | $123.12 | $5,047.97 |
DisclosureSEC source: 0000310764-17-000019 · wf-form4_148605988609191.xml · nonDerivative · entry 1 Doliveux Roch · CIK 0001494947 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,709 Read SEC document |
| January 31, 2017 Filed Feb 5, 2018 21:22 UTC |
Doliveux RochDirector
|
PurchaseCommon Stock | 43 | $164.94 | $7,092.52 |
DisclosureSEC source: 0000310764-18-000021 · wf-form4_151786574087248.xml · nonDerivative · entry 1 Doliveux Roch · CIK 0001494947 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,797 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.